Global mRNA cancer vaccine market 2019


Report ID : RC-3016 Category : Healthcare Published Date : 2019
Publisher : QYResearch Pages : 144 Format : PDF
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
In 2019, the global mRNA Cancer Vaccines and Therapeutics market size was 68 million US$ and it is expected to reach 320 million US$ by the end of 2026, with a CAGR of 21.5% during 2019-2026

This report focuses on the global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.

The key players covered in this study

    Moderna Therapeutics

    CureVac

    Translate Bio

    BioNTech

    Sangamo Therapeutics

    Argos Therapeutics

    In-Cell-Art

    eTheRNA

    Ethris

    Tiba Biotechnology

Market segment by Type, the product can be split into

    Adeno Carcinomas

    Mucinous Carcinomas

    Adenosquamous Carcinomas

Market segment by Application, split into

    Infectious Disease

    Cancer

    Other

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players.

    To present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.


    

Global MRNA cancer vaccine Market Research Report 2019-2026

Chapter 1 MRNA cancer vaccine Market Overview
1.1 Product Overview and Scope of MRNA cancer vaccine
1.2 MRNA cancer vaccine Market Segmentation by Type
1.2.1 Global Production Market Share of MRNA cancer vaccine by Type in 2019
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 MRNA cancer vaccine Market Segmentation by Application
1.3.1 MRNA cancer vaccine Consumption Market Share by Application in 2019
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 MRNA cancer vaccine Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of MRNA cancer vaccine (2019-2026)

Chapter 2 Global Economic Impact on MRNA cancer vaccine Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global MRNA cancer vaccine Market Competition by Manufacturers
3.1 Global MRNA cancer vaccine Production and Share by Manufacturers (2019 and 2026)
3.2 Global MRNA cancer vaccine Revenue and Share by Manufacturers (2019 and 2026)
3.3 Global MRNA cancer vaccine Average Price by Manufacturers (2019 and 2026)
3.4 Manufacturers MRNA cancer vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 MRNA cancer vaccine Market Competitive Situation and Trends
3.5.1 MRNA cancer vaccine Market Concentration Rate
3.5.2 MRNA cancer vaccine Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion


Chapter 4 Global MRNA cancer vaccine Production, Revenue (Value) by Region (2019-2026)
4.1 Global MRNA cancer vaccine Production by Region (2019-2026)
4.2 Global MRNA cancer vaccine Production Market Share by Region (2019-2026)
4.3 Global MRNA cancer vaccine Revenue (Value) and Market Share by Region (2019-2026)
4.4 Global MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.5 North America MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.6 Europe MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.7 China MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.8 Japan MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.9 Southeast Asia MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)
4.10 India MRNA cancer vaccine Production, Revenue, Price and Gross Margin (2019-2026)

Chapter 5 Global MRNA cancer vaccine Supply (Production), Consumption, Export, Import by Regions (2019-2026)
5.1 Global MRNA cancer vaccine Consumption by Regions (2019-2026)
5.2 North America MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)
5.3 Europe MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)
5.4 China MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)
5.5 Japan MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)
5.6 Southeast Asia MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)
5.7 India MRNA cancer vaccine Production, Consumption, Export, Import by Regions (2019-2026)

Chapter 6 Global MRNA cancer vaccine Production, Revenue (Value), Price Trend by Type
6.1 Global MRNA cancer vaccine Production and Market Share by Type (2019-2026)
6.2 Global MRNA cancer vaccine Revenue and Market Share by Type (2019-2026)
6.3 Global MRNA cancer vaccine Price by Type (2019-2026)
6.4 Global MRNA cancer vaccine Production Growth by Type (2019-2026)

Chapter 7 Global MRNA cancer vaccine Market Analysis by Application
7.1 Global MRNA cancer vaccine Consumption and Market Share by Application (2019-2026)
7.2 Global MRNA cancer vaccine Consumption Growth Rate by Application (2019-2026)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 MRNA cancer vaccine Manufacturing Cost Analysis
8.1 MRNA cancer vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of MRNA cancer vaccine

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 MRNA cancer vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of MRNA cancer vaccine Major Manufacturers in 2018
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global MRNA cancer vaccine Market Forecast (2019-2026)
12.1 Global MRNA cancer vaccine Production, Revenue Forecast (2019-2026)
12.2 Global MRNA cancer vaccine Production, Consumption Forecast by Regions (2019-2026)
12.3 Global MRNA cancer vaccine Production Forecast by Type (2019-2026)
12.4 Global MRNA cancer vaccine Consumption Forecast by Application (2019-2026)
12.5 MRNA cancer vaccine Price Forecast (2019-2026)

Chapter 13 Appendix








Sidebar Menu